Gerald Wertheim
- Hematology top 2%
- Acute Myeloid Leukemia Research 30
- Chronic Myeloid Leukemia Treatments 12
- Oncology top 5%
- CAR-T cell therapy research 7
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 7
- Immunology top 10%
- Immune Cell Function and Interaction 9
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 13
-
- Acute Lymphoblastic Leukemia research 20
-
- Epigenetics and DNA Methylation 9
- Co-authors
- Lewis A. ChodoshAdam BaggJennifer HartmanGeorge K. BelkaJames Z. WangRobert BoxerEdward J. GuntherMartin Carroll
- Cited by
- HematologyOncologyGenetics
- Partner nations
- United StatesNetherlandsFrance
In The Last Decade
Gerald Wertheim
80 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 105
- Hematology 405
- Oncology 523
- Genetics 136
- Immunology 257
- Cancer Research 165
Countries citing papers authored by Gerald Wertheim
This map shows the geographic impact of Gerald Wertheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Wertheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Wertheim more than expected).
Fields of papers citing papers by Gerald Wertheim
This network shows the impact of papers produced by Gerald Wertheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Wertheim. The network helps show where Gerald Wertheim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gerald Wertheim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 11 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 0 | |
| 7 | 2021 | 22 | |
| 8 | 2020 | 50 | |
| 9 | 2020 | 32 | |
| 10 | 2020 | 4 | |
| 11 | 2020 | 11 | |
| 12 | 2019 | 24 | |
| 13 | 2017 | 44 | |
| 14 | 2017 | 15 | |
| 15 | 2017 | 6 | |
| 16 | 2017 | 2 | |
| 17 | Familial Monosomy 7 Syndrome | 2016 | 1 |
| 18 | 2016 | 18 | |
| 19 | 2012 | 10 | |
| 20 | 2008 | 17 |
About Gerald Wertheim
Gerald Wertheim is a scholar working on Hematology, Genetics, Cancer Research, Oncology and Public Health, Environmental and Occupational Health, having authored 83 papers that have together received 1.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (30 papers), Acute Lymphoblastic Leukemia research (20 papers), Cancer Genomics and Diagnostics (13 papers), Chronic Myeloid Leukemia Treatments (12 papers), Epigenetics and DNA Methylation (9 papers), Immune Cell Function and Interaction (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and CAR-T cell therapy research (7 papers). The work is most often cited by research in Hematology (405 citations), Oncology (523 citations), Genetics (136 citations), Immunology (257 citations) and Cancer Research (165 citations). Gerald Wertheim has collaborated with scholars based in United States, Netherlands and France. Frequent co-authors include Lewis A. Chodosh, Adam Bagg, Jennifer Hartman, George K. Belka, James Z. Wang, Robert Boxer, Edward J. Gunther, Martin Carroll, Shannon L. Maude and Vijay Bhoj. Their work appears in journals such as Blood, Leukemia, Pediatric Blood & Cancer, Blood Advances and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.